Empirical Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Buy
1,522
+436
+40% +$155K 0.14% 203
2025
Q4
$355K Buy
1,086
+1
+0.1% +$317 0.1% 240
2025
Q3
$306K Sell
1,085
-3,188
-75% -$925K 0.09% 290
2025
Q2
$1.19M Buy
4,273
+3,172
+288% +$899K 0.37% 73
2025
Q1
$343K Sell
1,101
-5,939
-84% -$1.75M 0.12% 236
2024
Q4
$300K Buy
7,040
+3,156
+81% +$936K 0.1% 226
2024
Q3
$366K Sell
3,884
-42
-1% -$13.7K 0.13% 203
2024
Q2
$368K Buy
+3,926
New +$1.15M 0.14% 215
2023
Q3
Sell
-2,889
Closed -$641K 169
2023
Q2
$641K Buy
+2,889
New +$670K 0.57% 60

Other funds holding AMGN

Empirical Asset Management's AMGN Position: Q1 2026 in Review

Empirical Asset Management increased its Amgen (AMGN) stake by 40% in Q1 2026, buying an estimated $155K and bringing the position to 1,522 shares worth $535K. The position accounts for 0.14% of the portfolio, ranked #203.

Empirical Asset Management first reported a position in AMGN in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.19M in Q2 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Empirical Asset Management held 1,522 shares of Amgen worth $535K as of Q1 2026.
  • Empirical Asset Management bought 436 Amgen shares in Q1 2026, an estimated $155K.
  • Amgen made up 0.14% of Empirical Asset Management's portfolio in Q1 2026, its #203 holding.
  • Empirical Asset Management first reported a position in Amgen in Q2 2023 and has held it in 9 quarters since.
  • Empirical Asset Management's Amgen position peaked at $1.19M in Q2 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Empirical Asset Management's 13F filing for Q1 2026, filed 11 May 2026.